|
ZBED3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.07813757921349E-12 |
| Normal-vs-Stage2 |
4.85120055238042E-10 |
| Normal-vs-Stage3 |
1.64557256709941E-12 |
| Normal-vs-Stage4 |
1.73210001896962E-10 |
| Stage1-vs-Stage2 |
4.061200E-01 |
| Stage1-vs-Stage3 |
3.997700E-02 |
| Stage1-vs-Stage4 |
5.414100E-02 |
| Stage2-vs-Stage3 |
4.856400E-01 |
| Stage2-vs-Stage4 |
4.284200E-01 |
| Stage3-vs-Stage4 |
8.634400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.664300E-03 |
| Normal-vs-Asian |
4.788600E-04 |
| Caucasian-vs-AfricanAmerican |
1.115990E-01 |
| Caucasian-vs-Asian |
9.920000E-01 |
| AfricanAmerican-vs-Asian |
5.367400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62492241884138E-12 |
| Normal-vs-Female |
4.98490138056695E-14 |
| Male-vs-Female |
9.504200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.058000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
1.72928338315614E-12 |
| Normal-vs-Age(81-100Yrs) |
9.23849885481332E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.776000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.647400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.955370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.025400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.973200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.691500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.591000E-01 |
| Normal-vs-Grade 2 |
1.63202784619898E-12 |
| Normal-vs-Grade 3 |
2.44804176929847E-13 |
| Normal-vs-Grade 4 |
5.48672218769752E-13 |
| Grade 1-vs-Grade 2 |
9.869900E-02 |
| Grade 1-vs-Grade 3 |
1.996060E-02 |
| Grade 1-vs-Grade 4 |
2.696600E-03 |
| Grade 2-vs-Grade 3 |
9.875400E-01 |
| Grade 2-vs-Grade 4 |
1.955780E-02 |
| Grade 3-vs-Grade 4 |
4.219700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.88178419700125E-16 |
| Normal-vs-ccB subtype |
3.5687008903551E-12 |
| ccA subtype-vs-ccB subtype |
8.577600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
1.25830001973526E-09 |
| N0-vs-N1 |
1.385960E-01 |
|
|
